3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
1
Leukemia, Plasma Cell
1
Leukemia, B-Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
4
gamma-Globulins
3
Ciprofloxacin
3
Immunoglobulins, Intravenous
2
Amoxicillin-Potassium Clavulanate Combination
2
talquetamab
1
plerixafor
1
idecabtagene vicleucel
1
anifrolumab
1
Wearable Electronic Devices
1
Vital Signs
1
Procalcitonin
1
Plastic Surgery Procedures
1
Immunoglobulins
1
Fish Oils
1
Ethanol
1
Enteral Nutrition
1
Dietary Supplements
1
Cystectomy
1
Control Groups
1
Clavulanic Acid
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Infections
×
idecabtagene vicleucel
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled